BIOLIFE SOLUTIONS INC
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
BLFS$38.61+3.5%Stored close · as of Oct 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| (In thousands, except per share and share data) | 2023 | 2022 |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $35,407 | $19,442 |
| Restricted cash | 31 | 31 |
| Available-for-sale securities, current portion | 16,288 | 43,260 |
| Accounts receivable, trade, net of allowance for credit losses of $1,710 and $739 as of December 31, 2023 and December 31, 2022, respectively | 18,657 | 33,936 |
| Inventories | 43,456 | 34,904 |
| Prepaid expenses and other current assets | 6,765 | 6,879 |
| Total current assets | 120,604 | 138,452 |
| Assets held for rent, net | 7,713 | 9,064 |
| Property and equipment, net | 21,077 | 23,638 |
| Operating lease right-of-use assets, net | 11,446 | 15,292 |
| Financing lease right-of-use assets, net | 94 | 272 |
| Long-term deposits and other assets | 273 | 281 |
| Available-for-sale securities, long term | 548 | 1,332 |
| Equity Investments | 5,069 | 5,069 |
| Intangible assets, net | 21,149 | 32,088 |
| Goodwill | 224,741 | 224,741 |
| Total assets | $412,714 | $450,229 |
| Liabilities and Shareholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $6,940 | $15,367 |
| Accrued expenses and other current liabilities | 11,932 | 9,782 |
| Sales taxes payable | 5,442 | 4,151 |
| Warranty liability | 7,858 | 8,312 |
| Lease liabilities, operating, current portion | 2,797 | 2,860 |
| Lease liabilities, financing, current portion | 376 | 158 |
| Debt, current portion | 6,833 | 1,814 |
| Contingent consideration, current portion | — | 2,138 |
| Total current liabilities | 42,178 | 44,582 |
| Contingent consideration, long-term | — | 2,318 |
| Lease liabilities, operating, long-term | 13,205 | 14,962 |
| Lease liabilities, financing, long-term | 1,169 | 126 |
| Debt, long-term | 18,311 | 23,793 |
| Deferred tax liabilities | 188 | 250 |
| Other long-term liabilities | — | 10 |
| Total liabilities | 75,051 | 86,041 |
| Commitments and contingencies (Note 12) | ||
| Shareholders’ equity: | ||
| Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding as of December 31, 2023 and December 31, 2022 | — | — |
| Common stock, $0.001 par value; 150,000,000 shares authorized, 45,167,225 and 42,832,231 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively | 45 | 43 |
| Additional paid-in capital | 651,305 | 611,739 |
| Accumulated other comprehensive loss, net of taxes | (345) | (679) |
| Accumulated deficit | (313,342) | (246,915) |
| Total shareholders’ equity | 337,663 | 364,188 |
| Total liabilities and shareholders’ equity | $412,714 | $450,229 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.